ABOUT PHARMA EXCIPIENTS

associated product failures for the reason that neither physicians nor buyers have all of the knowledge necessary to make ample judgments of product quality and lawful tort treatments are slow, inefficient, and very costly. The changes to the CGMP regulation would require manufacturers to extend [Web page 52644] their excellent methods to incorpora